Language selection

Search

Patent 2337240 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2337240
(54) English Title: DISTURBANCE-FREE ELECTROMYOGRAPHIC PROBE
(54) French Title: SONDE ELECTROMYOGRAPHIQUE DEPOURVUE DE PERTURBATIONS
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61B 5/296 (2021.01)
  • A61B 5/03 (2006.01)
  • A61B 5/392 (2021.01)
  • A61N 1/05 (2006.01)
(72) Inventors :
  • SINDERBY, CHRISTER (Canada)
(73) Owners :
  • UNIVERSITE DE MONTREAL
(71) Applicants :
  • UNIVERSITE DE MONTREAL (Canada)
(74) Agent: BKP GP
(74) Associate agent:
(45) Issued: 2011-01-25
(86) PCT Filing Date: 1999-07-16
(87) Open to Public Inspection: 2000-01-27
Examination requested: 2004-06-29
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/CA1999/000652
(87) International Publication Number: WO 2000003637
(85) National Entry: 2001-01-12

(30) Application Priority Data:
Application No. Country/Territory Date
2,243,382 (Canada) 1998-07-16

Abstracts

English Abstract


A myographic probe for detecting an electrical signal produced by a muscle and
for reducing the influence of electrode disturbances. The probe includes
electrodes and a disturbance reducing interface covering each electrode
thereby segragating the electrodes from the muscle. Electrode disturbances
include problems such as those related to the motion of the electrodes,
changes in the pressure applied to the electrode, and/or intermittent contact
with sourrounding tissue. The disturbance reducing interface is ion permeable
and is, when dry, less conductive than the electrodes. The disturbance
reducing interface may comprise a matrix of permeable material such as a mesh,
foam, or other porous materials. The probe may be in the form of a catheter
and be advantageously used in a human cavity such as the oesophagus. Another
advantage of the invention is the possibility of using electrodes which are
different from conventional wound wire electrodes.


French Abstract

L'invention concerne une sonde myographique permettant de détecter un signal électrique produit par un muscle et de réduire l'influence des perturbations dues aux électrodes. Cette sonde comporte des électrodes et une interface permettant de réduire les perturbations et recouvrant chaque électrode, ce qui permet de séparer les électrodes des muscles. Les perturbations dues aux électrodes englobent des problèmes liés au mouvement des électrodes, aux changements de pression subis par les électrodes et/ou un contact intermittent avec un tissu environnant. L'interface permettant de réduire les perturbations est perméable aux ions et, lorsqu'elle est sèche, moins conductrice que les électrodes. Cette interface peut comporter une matrice en matière perméable telle qu'une maille, de la mousse ou d'autre matières poreuses. La sonde peut se présenter sous la forme d'un cathéter et peut être avantageusement utilisée dans une cavité humaine telle que l'oesophage. Un autre avantage de l'invention réside dans la possibilité d'utiliser des électrodes qui sont différentes des fils-électrodes enroulés classiques.

Claims

Note: Claims are shown in the official language in which they were submitted.


CLAIMS
1. An electrode structure comprising an electrode support and
at least one pair of spaced apart electrodes mounted on the electrode
support to sense, in a wet environment of a living body, an electrical
signal produced by a muscle of the living body, characterized in that the
electrode structure further comprises a motion-artifact-reducing interface
applied to the electrodes of said pair to prevent direct contact between
living tissue of the body and the electrodes, wherein the motion-artifact-
reducing interface comprises a material:
permeable to ions present in bodily fluids of the wet
environment,
through which the electric signal produced by the
muscle is propagated toward the electrodes while reducing
motion artifacts; and
having, when dry, a tower conductivity than the
electrodes.
2. An electrode structure as recited in claim 1, characterized
in that the motion-artifact-reducing interface comprises individual
interfaces respectively applied to said electrodes.
3. An electrode structure as recited in claim 1, characterized
in that the motion-artifact-reducing interface is a single interface covering
the two electrodes of said pair.
4. An electrode structure as recited in claim 1, characterized
in that the ion-permeable material defines a matrix.

5. An electrode structure as recited in claim 4, characterized
in that said matrix comprises a mesh.
6. An electrode structure as recited in claim 4, characterized
in that said matrix comprises a foam.
7. An electrode structure as recited in claim 1, characterized
in that said ion-permeable material is porous to define a matrix.
8. An electrode structure as recited in claim 4, characterized
in that said matrix comprises nylon filaments.
9. An electrode structure as recited in any one of claims 1 to
6, characterized in that said electrode support comprises a catheter for
insertion in the living body.
10. An electrode structure as recited in claim 10, characterized
in that said catheter is an oesophageal catheter.
11. An electrode structure as recited in claim 9 or 10,
characterized in that the ion-permeable material covers the circumference
of the catheter.
12. An electrode structure as recited in any one of claims 1 to
11, characterized in that said at least one pair of electrodes comprises a
plurality of pairs of electrodes forming a longitudinal array of electrodes.
13. An electrode structure as recited in claim 12, characterized
in that said array of electrodes comprises at least one electrode angularly

offset from a longitudinal axis formed by the remaining electrodes of the
array.
14. A method of reducing motion artifacts applied to an
electrode structure comprising an electrode support and at least one pair
of spaced apart electrodes mounted on the electrode support to sense,
in a wet environment of a living body, an electrical signal produced try a
muscle of the living body, characterized in that said method comprises:
applying to the electrodes of said pair a motion-artifact-
reducing interface to prevent direct contact between living tissue
of the body and the electrodes, wherein applying the motion-
artifact-reducing interface comprises:
covering the electrodes with a material
permeable to ions present in bodily fluids of the wet
environment, and through which the electric signal
produced by the muscle is propagated toward the
electrodes while reducing motion artifacts; and
providing the material, when dry, with a lower
conductivity than the electrodes.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
1
DISTURBANCE-FREE ELECTROMYOGRAPHIC PROBE
BACKGROUND OF THE INVENTION
1. Field of the invention:
The present invention relates to an apparatus for reducing
disturbances induced in a signal measurement or recording, in particular,
but not exclusively, by movement of the electrodes or changes in the
pressure applied to the electrodes.
2. Brief description of the prior art:
Oesophageal recording of diaphragm electromyogram
(EMG) has traditionally been problematic due to the low amplitude of the
EMG signal relative to the artifactual disturbances such as, in particular,
the so-called electrode motion artifacts. At high gain settings, large
electrode motion artifacts lead to saturation of the output of the
preamplifier, thereby causing a temporary loss of the EMG signal. This
problem of the prior art makes EMG recording very difficult during
dynamic manoeuvres, such as for example rapid shallow breathing or
. panting.

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
2
OBJECTS AND SUMMARY OF THE INVENTION
A first object of the present invention is to provide a
technology capable of reducing disturbances induced in a measurement
or recording by:
- movements of detecting electrodes;
- changes in the pressure applied to these electrodes; or
- other mechanical influence on the electrodes, generally
referred to as motion artifacts.
Another object of the present invention is to reduce the
amplitude of motion artifacts relative to the amplitude of the EMG signal
to thereby reduce the possibility for saturation of the preamplifier.
A third object of the present invention is to overcome the
problems of the prior art related to low signal-to-artifact ratio.
A further object of the present invention is to improve bipolar
electrode measurements of diaphragm electromyogram (EMG).
In a preferred embodiment of the invention, there is
provided a measurement apparatus for detecting an electrical signal
produced by a muscle while reducing signal disturbances caused by
motion artifacts, the measurement apparatus comprises:
a) a probe;
b) at least one electrode mounted on said probe; and
c) a disturbance reducing interface attached to said probe

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
3
and covering said at least one electrode, the interface being
ion permeable and segregating said at least one electrode
from the muscle.
The objects, advantages and other features of the present
invention will become more apparent upon reading of the following non
restrictive description of preferred embodiments thereof, given by way of
example only with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
In the appended drawings:
Figure 1 is a schematic representation of a set-up of an
EMG analysis system;
Figure 2 is a side elevation view of the free end section of
an oesophageal catheter on which an array of electrodes of the EMG
analysis system of Figure 1 is mounted;
Figure 3 is a longitudinal, partial cross sectional view of the
free end section of the oesophageal catheter of Figure 2, showing an
individual matrix of permeable material applied to each separate
electrode of the array;
Figure 4 is a longitudinal, partial cross sectional view of the
free end section of the oesophageal catheter of Figure 2, showing a

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
4
continuous matrix of permeable material applied to and spanning the
entire electrode array;
Figure 5 is a partial perspective view of the free end section
of an oesophageal catheter, showing an array of semicircular electrodes
and a continuous matrix of permeable material applied to and spanning
the entire array of semicircular electrodes;
Figure 6 is a partial perspective view of the free end section
of an oesophageal catheter, showing an array of button electrodes which
can be circular, square, rectangular, or of any other shape, and a
continuous matrix of permeable material applied to and spanning the
entire array of button electrodes;
Figure 7 is a longitudinal, partial cross sectional view of the
free end section of an oesophageal catheter, showing an electrode
embedded in the material of the catheter, and a matrix of permeable
material applied to the embedded electrode;
Figure 8 is a longitudinal, partial cross sectional view of the
free end section of an oesophageal catheter, showing a stud electrode
and a matrix of permeable material applied to the stud electrode;
Figure 9 is a partial perspective view of the free end section
of the oesophageal catheter of Figure 7, showing an array of electrodes
such as shown in Figure 7, embedded into the material of the catheter;
Figure 10 is a partial perspective view of the free end

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
section of an oesophageal catheter, showing an array of button
electrodes covered by a matrix of permeable material applied to the outer
surface of the oesophageal catheter;
5 Figure 11 is a partial perspective view of the free end
section of an oesophageal catheter, showing an array of button
electrodes as well as an array of grounding electrodes; and
Figure 12 is an end cross sectiorial view of the array of
button electrodes of Figure 10 covered by the matrix applied to the outer
surface of the oesophageal catheter.
DETAILED DESCRIPTION OF THE PREFERRED
EMBODIMENTS
The present invention relates to a technology capable of
reducing disturbances induced in an electrical signal measurement and/or
recording by movement of detecting electrodes or changes in the
pressure applied to these electrodes. The electrodes are conductive
elements used to detect electrical activity. The range of applications of
the present invention includes electrical signal measurement and/or
recording wherein electrodes are immersed in an eleclectrolyte (so-called
wet electrodes). A typical example is the measurement and/or recording
of diaphragm electromyogram (EMG), oesophageal peristalsis, or ECG
with electrodes positioned on a catheter which in turn is introduced in the
oesophagus.

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
6
Although the preferred embodiments will be described
hereinafter with reference to oesophageal catheters and an application
to the measurement of diaphragm electromyogram (EMG), it should be
kept in mind that it is within the scope of the present invention to envisage
other applications for this technology using other types of catheters or
probes.
Referring to Figures 1 and 2, to measure EMG activity of the
diaphragm 11 of a human patient 14, an array of electrodes such as 12
are mounted on the free end section 15 of an oesophageal catheter 13,
with an inter-electrode distance d (Figure 2). The distance d is adjusted
in relation to body size; distance d will be larger for an adult than for an
infant. The catheter 13 is a hollow tube having a diameter related to body
size; the diameter will be smaller for infants than for adults. The catheter
diameter, electrode size as well as the inter-electrode distance d may
also vary in relation to the purpose of the catheter use.
As shown in Figure 1, the catheter 13 is introduced into the
patient's oesophagus through one nostril or the mouth until the array of
electrodes 12 is situated at the level of the gastro-oesophageal junction.
Of course, positioning of the electrode array comprising a series of
differentially and axially arranged electrode pairs (for example electrode
pairs 1-7 of Figure 2) is guided by the electrocardiographic (ECG)
recordings and the diaphragm EMG. Alternatively, the electrodes 12 are
monopolar electrodes differentiated in a computer, for example computer
19 of Figure 1. When required, ground is obtained through a separate
grounding electrode structure 25 (Figure 1).

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
7
Positioning of an electrode at the oesophageal hiatus
(where the oesophagus passes through the diaphragm is guided by visual
inspection and/or computer algorithms studying the intensity, shape and
polarity of ECG and diaphragm EMG signals. When the electrode is
close to the oesophageal hiatus, i.e. next to the heart, ECG signal
amplitude is high. If the electrode array is positioned close to the mouth
(away from the heart), ECG signals present lower amplitudes at the
proximate electrodes, and higher amplitudes at the distal electrodes. If
the electrode array is positioned too far in the stomach, ECG has a high
amplitude at the proximate electrodes of the array and a low amplitude at
the distal electrodes. If the electrode array spans the region of the heart,
ECG signals will show a time shift along the electrode array. If the
electrodes are positioned away from the heart, ECG signals show no time
lag. Diaphragm EMG signals obtained through electrode pairs located
above and below the diaphragm have opposite polarities {with no time
shift). EMG signals obtained on the same side of the diaphragm show
the same polarity {and no time shift). The characteristics described in this
paragraph will help the operator to adequately position the array of
electrodes.
According to a preferred embodiment, an electrode 12 is
mounted on the free end section 15 of the catheter 13 by winding
stainless steel wire (not shown) around catheter 13. The wound stainless
steel wire presents a rough surface smoothed out by solder, which in tum
is electroplated with nickel, copper and then gold or silver. Use of other
metallic elements such as semicylindrical electrodes 21 (Figure 5), button
electrodes 22 and 23 (Figure 6), etc., could be contemplated. The button
electrodes can be arranged into a longitudinal linear array {electrodes

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
8
22), or at least one button electrode (see 23) can be angufarly offset from
the electrodes 22 about the longitudinal axis of the catheter section 15.
For larger diameter feeding tubes or catheters, electrodes
such as electrode 26 in Figure 7 can be embedded into the material 27
of the feeding tube or catheter 28. Figure 9 shows a longitudinal array of
electrodes 26 embedded into the material 27 of the free end section of
the oesophageal catheter 28. figure 9 also shows the electric wires such
as 30, embedded in the material 27 of the catheter 28, and individually
connecting each electrode 26 to the amplifiers 16 of Figure 1. In the
example of Figures 7 and 9, the electrodes 26 are oval. The electric
wires such as 30 in Figure 9 individually connect each electrode such as
26 with a respective input of the monopolar or differential (depending on
the monopolar or differential arrangement of the electrodes 12 or 26)
amplifiers 16 (Figure 1 ). Obviously, these electric wires 30 follow the
catheter such as 28 from the respective electrodes such as 26 to the
corresponding amplifiers 16; the electric wires 30 can be embedded in the
material such as 27 of the catheter such as 28 or passed separately
outside (see for example 45 in Figure 10) or inside (see for example 46
in Figure 10) the catheter lumen 47 depending on the intended
application. The electric wires such as 30 transmitting the EMG signals
collected by the various electrodes such as 26 are necessarily electrically
insulated from each other and preferably surrounded by a conductive
mesh constituting a shield against external disturbances.
Referring now to Figure 8, a stud electrode 31 is illustrated.
Each stud electrode 31 is mounted in a hole 32 made through the wall of
an oesophageal catheter 33.

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
9
The electrodes such as 34 in Figure 10 can also be applied
by means of glue or any other suitable adhesive material or compound,
including double adhesive tape.
In the example of Figures 10 and 12, a linear array of oval
electrodes 34 is mounted on the outer surface 44 of a catheter 36
comprising two longitudinal lumens 47 and 48. Referring to Figure 12,
each electrode 34 is applied to the catheter surface 44. As described in
the foregoing description, the electric wires (see 45 and 46) for
individually connecting the electrodes 34 to the amplifiers 16 will extend
either inside lumen 47 (see 46 in Figure 10), inside lumen 48, outside the
catheter 36 (see 45 in Figure 10), or embedded in the material of the
catheter 36.
Figure 11 is a partial perspective view the free end section
of an oesophageal catheter 37, comprising a longitudinal, linear array of
button electrodes 38. Figure 11 also shows an example of grounding
electrode structure (see 25 in Figure 1). In the example of Figure 11, the
grounding electrode structure comprises a helical array of grounding
electrodes 39 mounted on the outer surface 40 of the catheter 37. Of
course, the array of grounding electrodes 39 is centered on the
longitudinal axis of the catheter 37 and presents the general configuration
of a cylindrical helix.
Pressure sensors, pH sensors, thermistors and other
detector devices can be added onto the catheter in accordance with the
requirements of the intended application.

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
Referring back to Figure 1, the group of amplifiers 16
amplifies and band-pass filters each EMG signal. The amplified EMG
signals are sampled by a personal computer 19 through respective
isolation amplifiers of a unit 18, to form signal segments of fixed duration.
5 Unit 18 supplies electric power to the various electronic components of
the amplifiers 16 and isolation amplifiers while ensuring adequate
isolation of the patient's body from such power supply. The unit 18 also
incorporates bandpass filters included in the respective EMG signal
channels to eliminate the effects of aliasing. The successive EMG signal
10 segments are then digitaAy processed into the personal computer 19 after
analog-to-digital conversion thereof. This analog-to-digital conversion is
conveniently carried out by an analog-to-digital converter implemented in
the personal computer 19. The personal computer 19 includes a monitor
40 and a keyboard 41.
It is believed to be within the capacity of those of ordinary
skill in the art to construct suitable amplifiers 16 and an adequate isolation
amplifiers and power supply unit 18. Accordingly, the amplifiers 16 and
the unit 18 will not be further described in the present specification.
To eliminate the problems related to motion of the electrode,
changes in the pressure applied to the electrode, andlor intermittent
contact with surrounding tissue, a motion artifact reducing interface is
applied to the electrode surface. The problems listed above can grouped
as disturbances; the motion artifact reducing interface may therefore also
be referred to as a disturbance reducing interface. The motion artifact
reducing interface advantageously consists of a matrix of permeable
material comprising, for example, a mesh, foam or other porous material,

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
11
e.g. a fine filament matrix of nylon. The principle of operation is that the
matrix of permeable material creates an interface that hosts ions and
electrodes and prevents direct contact between the metal surface of the
electrode and the surrounding body tissue. The type of permeable
material and thickness thereof is not crucial for performance as long as
it forms an ion saturated interface producing no direct contact between
the electrode and body tissue. However, excessive thickness may cause
increased distance between the electrode and muscle, which will weaken
the signal strength and lower the frequency content of this signal.
As illustrated in Figures 3-8 and 10, the matrix of permeable
material is applied to the exposed surface of the electrodes where the ion
concentration gradients are largest to reduce mechanically-caused
movements of ions.
The matrix can be formed by separate single matrices 17
{Figure 3), 29 {Figure 7) or 42 (Figure 8) individually applied to or
integrated in the exposed surface of each electrode 12 (Figure 3), 26
(Figure 7) or 31 (Figure 8). For example, each individual matrix 17, 29 or
42 can be glued on, or adhere to by other means, the outer surface of the
catheter to cover the associated electrode. However no adhesive material
may cover the electrode surface.
The matrix can also take the form of a continuous matrix 20
(Figures 4, 5 and 6) or 35 (Figure 10 and 12). For example, the
continuous matrix may form a tube that can be pulled over the catheter
to cover the entire span of the array of electrodes 12 (Figure 4), 21
(Figure 5), 22 and 23 (Figure 6), and 34 (Figures 10 and 12). In the case

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
12
of a continuous matrix spanning the entire electrode array, the
conductivity of the material constituting the matrix, when dry, has to
present a conductivity lower than the conductivity of the metal forming the
electrodes, whereby electrical conduction is carried out across the matrix,
i.e., through the electrolyte. These matrices provide a much more stable
voltage with a reduction of the so-called electrode motion induced
artifacts on the diaphragm EMG signal.
Also, the matrix can either cover the entire circumference
of the catheter (see matrices 20 and 17 of Figures 3-6) or a portion of the
circumference of the catheter (see matrices 29, 42 and 35 of Figures 7,
8, 10 and 12). Again these matrices can be adhered to the outer surface
of the catheter to cover the electrodes; no adhesive material may cover
the electrode surface.
Other alternatives (not shown) are ( a) to wind or wrap the
matrix around the catheter and the electrodes, and ( b) to host or embed
the electrodes into the matrix.
The electrode structure according to the invention can be
applied to measurement of the diaphragm electromyogram (EMG)
exclusively or in combination with a device for providing
feedinglmedication/liquid supply to the patient, and emptying of gastric
liquids, common to the treatment of patients in need of ventilatory
support. The electrode structure is usable to provide diaphragm EMG
signals from a plurality of conductive elements which in turn can be used
to:

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
13
- monitor diaphragm EMG (frequency, amplitude or power);
- trigger and control gas flow, gas volume or gas pressure
delivered by a mechanical lung ventilator; and
- control a closed loop ventilator system that will
automatically adjust the level of inspiratory support in
proportion to changes in the neuro-ventilatory efficiency
such that the neural drive remains stable at a desired target
level.
The closed loop ventilator system control can further use the
intensity of the diaphragm electromyogram (EMG) obtained immediately
before inspiratory flow occurs to quantify pre-inspiratory breathing efforts.
The catheter including the array of electrodes is aimed to be
disposed of after a single use; however, when desired, conventional
sterilization techniques can be applied in view of re-using the catheter.
The catheter can stay in the same patient for extensive periods of time;
it is therefore important that the electrodes and matrix be made out of a
non-allergen material.
Retrocardiac recording of electrocardiogram and
oesophageal peristalsis are other possible applications.
The electrode structure according to the invention is
applicable in all patients on ventilatory support and will enhance the
possibility of obtaining spontaneous breathing and of optimizing patient
ventilator interaction. There exists also a utility for this electrode
structure
during anaesthesia for monitoring vital fonctions of the patient. The

CA 02337240 2001-O1-12
WO 00/03637 PCT/CA99/00652
14
electrode structure can be used in connection with all kinds of ventilator
systems in intensive care unit settings or other wards where assisted
ventilation is required.
Although the present invention has been described
hereinabove with reference to preferred embodiments thereof, these
embodiments can be modified at will, within the scope of the appended
claims, without departing from the spirit and nature of the subject
invention.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2021-11-13
Inactive: IPC deactivated 2021-11-13
Inactive: First IPC assigned 2021-08-30
Inactive: IPC assigned 2021-08-30
Inactive: IPC assigned 2021-08-30
Time Limit for Reversal Expired 2018-07-16
Letter Sent 2017-07-17
Grant by Issuance 2011-01-25
Inactive: Cover page published 2011-01-24
Pre-grant 2010-11-12
Inactive: Final fee received 2010-11-12
Notice of Allowance is Issued 2010-10-01
Letter Sent 2010-10-01
Notice of Allowance is Issued 2010-10-01
Inactive: Approved for allowance (AFA) 2010-09-29
Amendment Received - Voluntary Amendment 2009-02-04
Inactive: S.30(2) Rules - Examiner requisition 2008-08-05
Amendment Received - Voluntary Amendment 2008-02-13
Inactive: S.30(2) Rules - Examiner requisition 2007-08-17
Inactive: S.29 Rules - Examiner requisition 2007-08-17
Inactive: Office letter 2007-04-13
Inactive: Corrective payment - s.78.6 Act 2006-07-10
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Amendment Received - Voluntary Amendment 2004-08-26
Letter Sent 2004-07-23
Request for Examination Received 2004-06-29
Request for Examination Requirements Determined Compliant 2004-06-29
All Requirements for Examination Determined Compliant 2004-06-29
Revocation of Agent Requirements Determined Compliant 2002-12-02
Inactive: Office letter 2002-12-02
Inactive: Office letter 2002-12-02
Appointment of Agent Requirements Determined Compliant 2002-12-02
Revocation of Agent Request 2002-11-08
Appointment of Agent Request 2002-11-08
Letter Sent 2001-12-12
Inactive: Entity size changed 2001-12-11
Reinstatement Requirements Deemed Compliant for All Abandonment Reasons 2001-11-23
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2001-07-16
Letter Sent 2001-07-13
Inactive: Single transfer 2001-06-01
Inactive: Cover page published 2001-04-20
Inactive: First IPC assigned 2001-04-10
Inactive: Courtesy letter - Evidence 2001-04-03
Inactive: Notice - National entry - No RFE 2001-03-27
Application Received - PCT 2001-03-20
Application Published (Open to Public Inspection) 2000-01-27

Abandonment History

Abandonment Date Reason Reinstatement Date
2001-07-16

Maintenance Fee

The last payment was received on 2010-07-08

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
UNIVERSITE DE MONTREAL
Past Owners on Record
CHRISTER SINDERBY
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative drawing 2001-04-20 1 11
Abstract 2001-01-12 1 65
Description 2001-01-12 14 509
Claims 2001-01-12 3 99
Drawings 2001-01-12 4 105
Cover Page 2001-04-20 2 71
Description 2008-02-13 14 517
Claims 2008-02-13 3 85
Description 2009-02-04 14 518
Claims 2009-02-04 3 86
Representative drawing 2011-01-04 1 16
Cover Page 2011-01-04 2 57
Reminder of maintenance fee due 2001-03-27 1 111
Notice of National Entry 2001-03-27 1 193
Courtesy - Certificate of registration (related document(s)) 2001-07-13 1 112
Courtesy - Abandonment Letter (Maintenance Fee) 2001-12-11 1 183
Notice of Reinstatement 2001-12-12 1 171
Reminder - Request for Examination 2004-03-17 1 116
Acknowledgement of Request for Examination 2004-07-23 1 177
Commissioner's Notice - Application Found Allowable 2010-10-01 1 163
Maintenance Fee Notice 2017-08-28 1 182
Maintenance Fee Notice 2017-08-28 1 181
Fees 2012-07-13 1 156
Correspondence 2001-03-27 1 24
PCT 2001-01-12 15 525
Correspondence 2002-11-08 3 75
Correspondence 2002-12-02 1 14
Correspondence 2002-12-02 1 17
Fees 2003-05-27 1 31
Fees 2001-11-23 1 47
Fees 2001-05-08 1 38
Fees 2002-06-28 1 43
Fees 2004-06-29 1 28
Fees 2005-05-30 1 29
Fees 2006-06-20 1 30
Correspondence 2007-04-13 1 14
Fees 2007-06-05 1 29
Correspondence 2007-01-31 5 165
Fees 2008-06-10 1 29
Fees 2009-07-15 1 29
Correspondence 2010-11-12 1 29